InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Vance Dolly, Directeur Exécutif. Officer active across 1 company, notably RIGEL PHARMACEUTICALS INC. Aggregated, 1 reports have been recorded. History available since 24 January 2022. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Vance Dolly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
About Vance Dolly
VANCE DOLLY is the Executive Vice President of Corporate Affairs, General Counsel, and Secretary at RIGEL PHARMACEUTICALS INC. She oversees the company's legal affairs and regulatory compliance. Her role is essential in ensuring that the organization adheres to laws while pursuing its business objectives.
